Tumor Susceptibility Gene 101 (TSG101) (N-Term) Peptid
TSG101
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle TSG101 Produkte
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- MMRSRSKSPR RPSPTARGAN CDVELLKTTT RDREELKCML EKYERHLAEI
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-TSG10 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
- Hintergrund
-
TSG10 may play a role in the sperm tail fibrous sheath, a major sperm tail structure.
Alias Symbols: TSGA10,CEP4L,
Protein Size: 297 - Gen-ID
- 80705
-
Sie sind hier:
